Xtant Medical reports FY2025 net income $5.0M vs loss $16.5M; revenue $134M (+14% YoY)

Xtant Medical Holdings, Inc.

2026-Q1 EPS reported -$0.02 vs consensus -$0.02 ▼ miss (-17.6%)

Full-year 2025 revenue $134.0M (+14% YoY); net income $5.0M ($0.03 diluted EPS) vs net loss $16.5M in 2024.
Q4 2025 revenue $32.4M (+3% YoY); net income $0.1M vs net loss $3.2M; non-GAAP adjusted EBITDA $1.9M vs $0.4M.
Completed sale of non-core Coflex/CoFix assets and international hardware to Companion Spine for $21.4M cash.
Launched nanOss Strata synthetic bone graft and CollagenX bovine collagen product; total cash $17.3M at Dec 2025 + $10.5M received Feb 2026.
FY2026 revenue guidance $95M-$99M reflecting divestiture impact and cessation of license revenue; expects free cash flow positive.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Xtant Medical Holdings, Inc. reported Fourth Quarter 2025 results: revenue $32.4 million, net income $0.1 million.

Period: Fourth Quarter 2025
Revenue: $32.4 million
Net income: $0.1 million
Result: reported results

Exact text from the filing

Fourth quarter 2025 revenue grew 3% to $32.4 million, compared to $31.5 million for the same period in 2024.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Xtant Medical Holdings, Inc. reported Full Year 2025 results: revenue $134.0 million, net income $5.0 million, EPS $0.03 per diluted share.

Period: Full Year 2025
Revenue: $134.0 million
Net income: $5.0 million
EPS: $0.03 per diluted share
Result: reported results

Exact text from the filing

and may be different from non-GAAP finan --- EX-99.1 (EX-99.1) --- Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results Full year 2025 revenue totals $133.9 million, an increase of 14% year-over-year Xtant delivers positive net income, adjusted EBITDA and operating cash flow Total cash of $17.3 million as of December 31, 2025 with an

View on SEC.gov

1349 earnings releases filed in the last 30 days. Browse all earnings releases →

Xtant Medical Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-013788

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.